UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4400-4406

2013

Volltextzugriff (PDF)

Feelings Related to the COVID-19 Pandemic Among Patients Treated in the Oncology Clinics (Poland)

Frontiers in psychology, 2021-04, Vol.12, p.647196

2021

Volltextzugriff (PDF)

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck

PloS one, 2012-03, Vol.7 (3), p.e33396-e33396

2012

Volltextzugriff (PDF)

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib

Postȩpy dermatologii i alergologii, 2016-02, Vol.1, p.52-56

2016

Volltextzugriff (PDF)

The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

Oncology, 2013-01, Vol.85 (5), p.278-282

2013

Volltextzugriff (PDF)

Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis

Contemporary oncology (Poznań, Poland), 2021-01, Vol.25 (3), p.147-152

2021

Volltextzugriff (PDF)

Pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as potential prognostic factors in patients with newly diagnosed ovarian cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16555-e16555

2015

Volltextzugriff (PDF)

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

Contemporary oncology (Poznań, Poland), 2016-01, Vol.1 (1), p.1-7

2016

Volltextzugriff (PDF)

The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab

Archives of medical science, 2015-04, Vol.11 (2), p.371-377

2015

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer

ESMO open, 2016, Vol.1 (2), p.e000039-e000039, Article e000039

2016

Volltextzugriff (PDF)

CHEK2 mutation in renal cell carcinoma (RCC): Single center experience

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.480-480

2017

Volltextzugriff (PDF)

PR111 TIME FACTOR FOR BREAST CANCER METASTASES DYNAMIC

Breast (Edinburgh), 2013-11, Vol.22, p.S57-S57

2013

Volltextzugriff (PDF)

The association of tumor lymphocyte infiltration with clinicopathological factors and survival in breast cancer

Polish journal of pathology, 2017, Vol.68 (1), p.26-32

2017

Volltextzugriff (PDF)

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer

Clinical cancer research, 2014-08, Vol.20 (16), p.4240-4250

2014

Volltextzugriff (PDF)

Toxicity related to first line, platinum-based chemotherapy in BRCA1-associated epithelial ovarian cancer: Is DNA repairing impairment associated with more adverse events?

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e17092-e17092

2016

Volltextzugriff (PDF)

Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1

Expert review of precision medicine and drug development, 2016-11, Vol.1 (6), p.479-485

2016

Volltextzugriff (PDF)

Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases

Przegla̜d menopauzalny, 2015-09, Vol.14 (3), p.173-177

2015

Volltextzugriff (PDF)

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

Contemporary oncology (Poznań, Poland), 2015, Vol.1 (1), p.72-76

2015

Volltextzugriff (PDF)

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma

European journal of haematology, 2013-08, Vol.91 (2), p.122-128

2013

Volltextzugriff (PDF)

Metaplastic breast carcinomas – analysis of prognostic factors in a case series

Contemporary oncology (Poznań, Poland), 2014-01, Vol.2 (2), p.116-119

2014

Volltextzugriff (PDF)

A Comparison between CHEK21100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis

Oncology, 2016, Vol.90 (4), p.193-198

2016

Volltextzugriff (PDF)

Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia

Postȩpy higieny i medycyny doświadczalnej, 2016-05, Vol.70, p.534-541

2016

Volltextzugriff (PDF)

Answer to the Teresa Pusiol comments to the paper "The association of tumor lymphocyte infiltration with clinico-pathological factor and survival in breast cancer" by Huszno et al

Polish journal of pathology, 2017-01, Vol.68 (3), p.269-269

2017

Volltextzugriff (PDF)

C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation

Hematology (Luxembourg), 2016-07, Vol.21 (6), p.343-350

2016

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(74)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(70)
Polnisch
(10)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Oncology
(22)
Humans
(21)
Middle Aged
(20)
Aged
(19)
Female
(19)
Adult
(16)
Breast Cancer
(12)
Male
(11)
Chemotherapy
(10)
Original Paper
(10)
Prognosis
(8)
Treatment Outcome
(8)
Retrospective Studies
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Kaplan-Meier Estimate
(6)
Aged, 80 And Over
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Radiotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Feelings Related to the COVID-19 Pandemic Among Patients Treated in the Oncology Clinics (Poland)

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib

The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis

Pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as potential prognostic factors in patients with newly diagnosed ovarian cancer

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer

CHEK2 mutation in renal cell carcinoma (RCC): Single center experience

PR111 TIME FACTOR FOR BREAST CANCER METASTASES DYNAMIC

The association of tumor lymphocyte infiltration with clinicopathological factors and survival in breast cancer

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer

Toxicity related to first line, platinum-based chemotherapy in BRCA1-associated epithelial ovarian cancer: Is DNA repairing impairment associated with more adverse events?

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1

Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma

Metaplastic breast carcinomas – analysis of prognostic factors in a case series

A Comparison between CHEK21100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis

Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia

Answer to the Teresa Pusiol comments to the paper "The association of tumor lymphocyte infiltration with clinico-pathological factor and survival in breast cancer" by Huszno et al

C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation

Suchergebnisse filtern